Unitree Clears CSRC Registration for ~$619M STAR Market IPO
Unitree Robotics cleared a major capital-markets checkpoint: China’s securities regulator approved the company’s STAR Market IPO registration, putting the Hangzhou robot maker on track for one of the most watched robotics listings in mainland China.
The Next Web, citing Reuters, reported the China Securities Regulatory Commission (CSRC) sign-off on July 3, 2026, with a planned raise of roughly ¥4.2 billion (~$619 million). Caixin Global reported the same approval path — SSE review opinion plus registration documents accepted — and framed the raise around R&D and production.
What the approval does — and does not — mean
Registration approval is not the same as shares trading. Unitree still needs to price and issue stock. TNW notes those steps typically follow registration by weeks, not days.
Timeline from reporting:
- March 20, 2026: Shanghai Stock Exchange accepted the IPO application (Caixin / SCMP)
- June 1, 2026: SSE listing committee cleared the deal after inquiries and an on-site inspection (SCMP)
- July 3, 2026: CSRC registration approval (Caixin, TNW/Reuters)
SCMP said Unitree aimed to offer at least 40.4 million shares (minimum ~10% stake) and raise ¥4.2 billion. The company has been a public-market bellwether for China’s humanoid wave; peers such as Dobot, Leju Robotics, and Deep Robotics are also chasing listings, according to SCMP.
Business mix: humanoids as the growth engine
Unitree started with quadrupeds in 2016 and pushed hard into humanoids. Its G1 product page lists a base price from $13.5K, with 23–43 joint motors depending on configuration and optional force-control hands on EDU variants.
SCMP reported Unitree generated ¥1.7 billion in revenue last year and said the firm posted the highest net profit among peers at ¥590.8 million in that coverage. TNW summarized Caixin reporting of 2025 revenue around ¥1.7 billion as well. Valuation estimates for the listing have ranged roughly $5.9B–$7B across stages, according to TNW — final number waits on offer price.
Caixin’s filing coverage earlier in the process described humanoids rising to a majority of revenue by late 2025 in the prospectus snapshot, with the company profitable since turning the corner in 2024.
A Human’s Take
Public markets are about to put real P&L on a company most people only know from kung-fu reels. Registration is paper; the hard part is whether unit economics and software hold after the roadshow. I’d rather watch shipment quality and software stickiness than the first-day pop. If Unitree prices cleanly and ships product that works a shift, the listing matters. If it’s mostly demo theater priced as infrastructure, the market will teach that lesson fast.